Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Three-color flow cytometric analysis of F4/80-Like Receptor expression on mouse bone marrow cells. Mouse bone-marrow cells were preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody (Mouse BD Fc Block™) (Cat. No. 553141/553142). The cells were then stained with APC Rat Anti-Mouse CD11b (Cat. No. 553312/561690) and PE Hamster Anti-Mouse CD11c (Cat. No. 553802/557401/561044) antibodies and either Alexa Fluor® 488 Rat IgG2a, κ Isotype Control (Cat. No. 557676, Left Panels) or Alexa Fluor® 488 Rat Anti-Mouse F4/80-Like Receptor antibody (Cat. No. 564227; Right Panels). Two-color flow cytometric dot plots showing the correlated expression patterns of CD11b (Upper Panels) or CD11c (Lower Panels) versus F4/80-Like Receptor (or Ig Isotype control staining) were generated from gated events with the forward and side light-scatter characteristics of viable bone marrow cells. Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System.
Three-color flow cytometric analysis of F4/80-Like Receptor expression on mouse bone marrow cells. Mouse bone-marrow cells were preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody (Mouse BD Fc Block™) (Cat. No. 553141/553142). The cells were then stained with APC Rat Anti-Mouse CD11b (Cat. No. 553312/561690) and PE Hamster Anti-Mouse CD11c (Cat. No. 553802/557401/561044) antibodies and either Alexa Fluor® 488 Rat IgG2a, κ Isotype Control (Cat. No. 557676, Left Panels) or Alexa Fluor® 488 Rat Anti-Mouse F4/80-Like Receptor antibody (Cat. No. 564227; Right Panels). Two-color flow cytometric dot plots showing the correlated expression patterns of CD11b (Upper Panels) or CD11c (Lower Panels) versus F4/80-Like Receptor (or Ig Isotype control staining) were generated from gated events with the forward and side light-scatter characteristics of viable bone marrow cells. Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System.
Immunohistofluorescent analysis of F4/80-Like Receptor expression by cells within C57BL/6 mouse spleen. A mouse spleen cryosection (5 µm) was fixed with BD Cytofix™ Fixation Buffer (Cat. No. 554655), blocked with 5% goat serum and 1% BSA diluted in 1x PBS, and stained with Alexa Fluor® 488 Rat Anti-Mouse F4/80-Like Receptor antibody (Cat. No. 564227, pseudo-colored red), BD Horizon™ BV480 Rat Anti-Mouse CD3 Molecular Complex antibody (Cat. No. 565642, pseudo-colored green), and Alexa Fluor® 647 Rat Anti-Mouse CD45R/B220 (Cat. No. 557683, pseudo-colored blue). Slides were mounted with ProLong® Gold and the images were captured on a standard epifluorescence microscope. Original magnification, 20x.
Immunohistofluorescent analysis of F4/80-Like Receptor expression by cells within C57BL/6 mouse spleen. A mouse spleen cryosection (5 µm) was fixed with BD Cytofix™ Fixation Buffer (Cat. No. 554655), blocked with 5% goat serum and 1% BSA diluted in 1x PBS, and stained with Alexa Fluor® 488 Rat Anti-Mouse F4/80-Like Receptor antibody (Cat. No. 564227, pseudo-colored red), BD Horizon™ BV480 Rat Anti-Mouse CD3 Molecular Complex antibody (Cat. No. 565642, pseudo-colored green), and Alexa Fluor® 647 Rat Anti-Mouse CD45R/B220 (Cat. No. 557683, pseudo-colored blue). Slides were mounted with ProLong® Gold and the images were captured on a standard epifluorescence microscope. Original magnification, 20x.
Three-color flow cytometric analysis of F4/80-Like Receptor expression on mouse bone marrow cells. Mouse bone-marrow cells were preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody (Mouse BD Fc Block™) (Cat. No. 553141/553142). The cells were then stained with APC Rat Anti-Mouse CD11b (Cat. No. 553312/561690) and PE Hamster Anti-Mouse CD11c (Cat. No. 553802/557401/561044) antibodies and either Alexa Fluor® 488 Rat IgG2a, κ Isotype Control (Cat. No. 557676, Left Panels) or Alexa Fluor® 488 Rat Anti-Mouse F4/80-Like Receptor antibody (Cat. No. 564227; Right Panels). Two-color flow cytometric dot plots showing the correlated expression patterns of CD11b (Upper Panels) or CD11c (Lower Panels) versus F4/80-Like Receptor (or Ig Isotype control staining) were generated from gated events with the forward and side light-scatter characteristics of viable bone marrow cells. Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System.
Three-color flow cytometric analysis of F4/80-Like Receptor expression on mouse bone marrow cells. Mouse bone-marrow cells were preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody (Mouse BD Fc Block™) (Cat. No. 553141/553142). The cells were then stained with APC Rat Anti-Mouse CD11b (Cat. No. 553312/561690) and PE Hamster Anti-Mouse CD11c (Cat. No. 553802/557401/561044) antibodies and either Alexa Fluor® 488 Rat IgG2a, κ Isotype Control (Cat. No. 557676, Left Panels) or Alexa Fluor® 488 Rat Anti-Mouse F4/80-Like Receptor antibody (Cat. No. 564227; Right Panels). Two-color flow cytometric dot plots showing the correlated expression patterns of CD11b (Upper Panels) or CD11c (Lower Panels) versus F4/80-Like Receptor (or Ig Isotype control staining) were generated from gated events with the forward and side light-scatter characteristics of viable bone marrow cells. Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System.
Immunohistofluorescent analysis of F4/80-Like Receptor expression by cells within C57BL/6 mouse spleen. A mouse spleen cryosection (5 µm) was fixed with BD Cytofix™ Fixation Buffer (Cat. No. 554655), blocked with 5% goat serum and 1% BSA diluted in 1x PBS, and stained with Alexa Fluor® 488 Rat Anti-Mouse F4/80-Like Receptor antibody (Cat. No. 564227, pseudo-colored red), BD Horizon™ BV480 Rat Anti-Mouse CD3 Molecular Complex antibody (Cat. No. 565642, pseudo-colored green), and Alexa Fluor® 647 Rat Anti-Mouse CD45R/B220 (Cat. No. 557683, pseudo-colored blue). Slides were mounted with ProLong® Gold and the images were captured on a standard epifluorescence microscope. Original magnification, 20x.
Immunohistofluorescent analysis of F4/80-Like Receptor expression by cells within C57BL/6 mouse spleen. A mouse spleen cryosection (5 µm) was fixed with BD Cytofix™ Fixation Buffer (Cat. No. 554655), blocked with 5% goat serum and 1% BSA diluted in 1x PBS, and stained with Alexa Fluor® 488 Rat Anti-Mouse F4/80-Like Receptor antibody (Cat. No. 564227, pseudo-colored red), BD Horizon™ BV480 Rat Anti-Mouse CD3 Molecular Complex antibody (Cat. No. 565642, pseudo-colored green), and Alexa Fluor® 647 Rat Anti-Mouse CD45R/B220 (Cat. No. 557683, pseudo-colored blue). Slides were mounted with ProLong® Gold and the images were captured on a standard epifluorescence microscope. Original magnification, 20x.
Three-color flow cytometric analysis of F4/80-Like Receptor expression on mouse bone marrow cells. Mouse bone-marrow cells were preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody (Mouse BD Fc Block™) (Cat. No. 553141/553142). The cells were then stained with APC Rat Anti-Mouse CD11b (Cat. No. 553312/561690) and PE Hamster Anti-Mouse CD11c (Cat. No. 553802/557401/561044) antibodies and either Alexa Fluor® 488 Rat IgG2a, κ Isotype Control (Cat. No. 557676, Left Panels) or Alexa Fluor® 488 Rat Anti-Mouse F4/80-Like Receptor antibody (Cat. No. 564227; Right Panels). Two-color flow cytometric dot plots showing the correlated expression patterns of CD11b (Upper Panels) or CD11c (Lower Panels) versus F4/80-Like Receptor (or Ig Isotype control staining) were generated from gated events with the forward and side light-scatter characteristics of viable bone marrow cells. Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System.
Three-color flow cytometric analysis of F4/80-Like Receptor expression on mouse bone marrow cells. Mouse bone-marrow cells were preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody (Mouse BD Fc Block™) (Cat. No. 553141/553142). The cells were then stained with APC Rat Anti-Mouse CD11b (Cat. No. 553312/561690) and PE Hamster Anti-Mouse CD11c (Cat. No. 553802/557401/561044) antibodies and either Alexa Fluor® 488 Rat IgG2a, κ Isotype Control (Cat. No. 557676, Left Panels) or Alexa Fluor® 488 Rat Anti-Mouse F4/80-Like Receptor antibody (Cat. No. 564227; Right Panels). Two-color flow cytometric dot plots showing the correlated expression patterns of CD11b (Upper Panels) or CD11c (Lower Panels) versus F4/80-Like Receptor (or Ig Isotype control staining) were generated from gated events with the forward and side light-scatter characteristics of viable bone marrow cells. Flow cytometric analysis was performed using a BD LSRFortessa™ Cell Analyzer System.
Immunohistofluorescent analysis of F4/80-Like Receptor expression by cells within C57BL/6 mouse spleen. A mouse spleen cryosection (5 µm) was fixed with BD Cytofix™ Fixation Buffer (Cat. No. 554655), blocked with 5% goat serum and 1% BSA diluted in 1x PBS, and stained with Alexa Fluor® 488 Rat Anti-Mouse F4/80-Like Receptor antibody (Cat. No. 564227, pseudo-colored red), BD Horizon™ BV480 Rat Anti-Mouse CD3 Molecular Complex antibody (Cat. No. 565642, pseudo-colored green), and Alexa Fluor® 647 Rat Anti-Mouse CD45R/B220 (Cat. No. 557683, pseudo-colored blue). Slides were mounted with ProLong® Gold and the images were captured on a standard epifluorescence microscope. Original magnification, 20x.
Immunohistofluorescent analysis of F4/80-Like Receptor expression by cells within C57BL/6 mouse spleen. A mouse spleen cryosection (5 µm) was fixed with BD Cytofix™ Fixation Buffer (Cat. No. 554655), blocked with 5% goat serum and 1% BSA diluted in 1x PBS, and stained with Alexa Fluor® 488 Rat Anti-Mouse F4/80-Like Receptor antibody (Cat. No. 564227, pseudo-colored red), BD Horizon™ BV480 Rat Anti-Mouse CD3 Molecular Complex antibody (Cat. No. 565642, pseudo-colored green), and Alexa Fluor® 647 Rat Anti-Mouse CD45R/B220 (Cat. No. 557683, pseudo-colored blue). Slides were mounted with ProLong® Gold and the images were captured on a standard epifluorescence microscope. Original magnification, 20x.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The 6F12 antibody reacts with a 7-transmembrane-domain protein, which is similar to the F4/80 macrophage antigen of the EGF-TM7 protein family and is encoded by the Emr4 gene. The FIRE protein is expressed on myeloid cells with a denditic cell (DC) developmental potential, including subsets of DC and macrophages in the spleen and lymph nodes, most resident peritoneal macrophages, many peripheral blood monocytes, and a subpopulation of bone-marrow myeloid-cell progenitors. The protein is not detected on peripheral T and B lymphocytes, and it is down-regulated on thioglycollate-elicited peritoneal macrophages and on dendritic cells activated by GM-CSF, IFN-γ, anti-CD40, and LPS. Using soluble biotinylated fusion protein, a FIRE ligand was detected on a mouse IgG+ B lymphoma cell line (A20), but not on myeloid, fibroblast, or T-cell lines, suggesting that the FIRE protein may be involved in immunoregulatory interactions between antigen-presenting cells and B lymphocytes.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.